Analysis of outcomes in metastatic pancreatic cancer: Real-world experience in academic cancer centers.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.4_suppl.458
Abstract: 458Background: FOLFIRINOX is an active regimen for metastatic pancreatic cancer demonstrating a median overall survival of 11.1 months at the expense of significant treatment-related toxicity. Dose modifications are routinely used in clinical practice however there… read more here.
Keywords: metastatic pancreatic; analysis outcomes; pancreatic cancer; cancer real ... See more keywords
Efficacy and Safety of the Combination of Durvalumab Plus Gemcitabine and Cisplatin in Patients with Advanced Biliary Tract Cancer: A Real-World Retrospective Cohort Study
Sign Up to like & getrecommendations! Published in 2025 at "Biomedicines"
DOI: 10.3390/biomedicines13081915
Abstract: Background/Objectives: The TOPAZ-1 phase III trial reported a survival benefit of using durvalumab, an anti-programmed death ligand 1 (anti-PD-L1) antibody, in combination with gemcitabine and cisplatin (GCD) treatment in patients with advanced biliary tract cancer.… read more here.
Keywords: cancer; tract cancer; biliary tract; cancer real ... See more keywords
CAPOX vs. FOLFOX for Colorectal Cancer—Real World Outcomes in Ontario, Canada
Sign Up to like & getrecommendations! Published in 2025 at "Current Oncology"
DOI: 10.3390/curroncol32080435
Abstract: Simple Summary In clinical trials, 5-fluorouracil (5-FU), leucovorin, and oxaliplatin (FOLFOX) and capecitabine and oxaliplatin (CAPOX) have been shown to be equally effective chemotherapy regimens for colorectal cancer. FOLFOX requires an inconvenient and failure-prone central… read more here.
Keywords: colorectal cancer; folfox colorectal; capox; capox folfox ... See more keywords